Literature DB >> 11222684

Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

J Gonsky1, E Bacharach, S P Goff.   

Abstract

The nucleocapsid (NC) protein of retroviruses is a small nucleic acid-binding protein important in virion assembly and in the encapsidation of the viral RNA genome into the virion particle. Multiple single-amino-acid substitutions were introduced into the NC of Moloney murine leukemia virus to examine further its role in viral replication. Two residues were shown to play important roles in the early events of replication. Unlike viruses with previously characterized NC mutations, these viruses showed no impairment in the late events of replication. Viruses containing the substitutions L21A and K30A expressed the normal complement of properly processed viral Gag proteins. Analysis of the RNA content of mutant virions revealed normal levels of unspliced and spliced viral RNA, and the tRNA(Pro) primer was properly annealed to the primer binding site on the viral genome. The virions demonstrated no defect in initiation of reverse transcription using the endogenous tRNA primer or in the synthesis of long viral DNA products in vitro. Nonetheless, viruses possessing these NC mutations demonstrated significant defects in the synthesis and accumulation of viral DNA products in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222684      PMCID: PMC115885          DOI: 10.1128/JVI.75.6.2616-2626.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

Authors:  A Cimarelli; S Sandin; S Höglund; J Luban
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Sequence and spacing requirements of a retrovirus integration site.

Authors:  J Colicelli; S P Goff
Journal:  J Mol Biol       Date:  1988-01-05       Impact factor: 5.469

3.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.

Authors:  C Méric; S P Goff
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Low-molecular- weight Rauscher leukemia virus protein with preferential binding for single-stranded RNA and DNA.

Authors:  J Davis; M Scherer; W P Tsai; C Long
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

7.  Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection.

Authors:  S Crawford; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase.

Authors:  P Schwartzberg; J Colicelli; M L Gordon; S P Goff
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.

Authors:  R J Gorelick; L E Henderson; J P Hanser; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA.

Authors:  A C Prats; L Sarih; C Gabus; S Litvak; G Keith; J L Darlix
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  14 in total

1.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.

Authors:  Suresh H Basagoudanavar; David H Perlman; Jianming Hu
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

3.  Ty3 nucleocapsid controls localization of particle assembly.

Authors:  Liza S Z Larsen; Nadejda Beliakova-Bethell; Virginia Bilanchone; Min Zhang; Anne Lamsa; Rhonda Dasilva; G Wesley Hatfield; Kunio Nagashima; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 4.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

5.  A structure-based mechanism for tRNA and retroviral RNA remodelling during primer annealing.

Authors:  Sarah B Miller; F Zehra Yildiz; Jennifer A Lo; Bo Wang; Victoria M D'Souza
Journal:  Nature       Date:  2014-09-07       Impact factor: 49.962

6.  Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.

Authors:  Sook-Kyung Lee; Kunio Nagashima; Wei-Shau Hu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting.

Authors:  Marcy R Auerbach; Chang Shu; Artem Kaplan; Ila R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

8.  Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.

Authors:  Silas F Johnson; John T Collins; Victoria M D'Souza; Alice Telesnitsky
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.

Authors:  Marcy R Auerbach; Kristy R Brown; Ila R Singh
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 10.  When is it time for reverse transcription to start and go?

Authors:  Marylène Mougel; Laurent Houzet; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2009-03-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.